Bicycle Therapeutics (BCYC) Invested Capital (2024)

Bicycle Therapeutics' (BCYC) quarterly Invested Capital came in at $22.4 million in Q2 2024.

Bicycle Therapeutics (BCYC) Invested Capital (2024) Analysis & Trends

Bicycle Therapeutics (BCYC) has 1 years of Invested Capital data on file, last reported at $22.4 million in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 190.90 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 2.57 Mn
7 Royalty Pharma 33.72 Bn 35.84 Bn - 380.00 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -
10 Bicycle Therapeutics 272.28 Mn 272.28 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2024 22.40 Mn